在 2026 年 Gartner(R)《供應鏈規劃解決方案：流程工業》魔力象限(TM) 報告中，OMP 在「願景完整性」與「執行能力」兩大指標上均位居首位
23:15 HKT/SGT |
|
|
在2026年Gartner(R)《供应链规划解决方案魔力象限(TM)：流程工业》报告中，OMP在“愿景完整性”和“执行能力”两项指标上均位居最高位置
23:15 HKT/SGT |
|
|
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries
23:15 HKT/SGT |
|
|
Wellgistics Health Inc. 簽署價值 1.05 億美元的意向書，以評估收購 Neuritek Therapeutics, Inc. 的可能性；該公司致力於開發治療神經系統及精神疾病的創新療法
21:05 HKT/SGT |
|
|
Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法
21:05 HKT/SGT |
|
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
21:05 HKT/SGT |
|
|
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share
20:51 HKT/SGT |
|
|
億勝生物科技2025全年業績穩健 收入升8.6%至18.14億港元 淨利潤升3.5%至3.18億港元 全年股息增加16.7%至每股14港仙
20:37 HKT/SGT |
|
|
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe
20:29 HKT/SGT |
|
|
亿胜生物科技2025全年业绩稳健 收入升8.6%至18.14亿港元 净利润升3.5%至3.18亿港元 全年股息增加16.7%至每股14港仙
20:13 HKT/SGT |
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
18:59 HKT/SGT |
|
|
雲頂新耀達成艾曲帕米鼻噴霧劑資產收購協議 強化心血管領域產品佈局
18:59 HKT/SGT |
|
|
云顶新耀达成艾曲帕米鼻喷雾剂资产收购协议 强化心血管领域产品布局
18:59 HKT/SGT |
|
|
同仁堂医养（02667.HK）新股招股：尚在发展早期的中医医疗龙头股 估值几何？
16:21 HKT/SGT |
|
|
同仁堂醫養（02667.HK）新股招股：尚在發展早期的中醫醫療龍頭股 估值幾何？
16:21 HKT/SGT |
|
|
From SGD to Global Spending: How Singaporeans Can Avoid FX Fees While Travelling Overseas
14:15 HKT/SGT |
|
|
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning
13:24 HKT/SGT |
|
|
中國新城鎮2025年內溢利大增35.5% 持續派息回饋股東
11:32 HKT/SGT |
|
|
中国新城镇2025年内溢利大增35.5% 持续派息回馈股东
11:10 HKT/SGT |
|
|
Hitachi Receives the 2026 Catalyst Award, a Global Recognition for Building an Inclusive Organization
10:49 HKT/SGT |
|
|
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
10:19 HKT/SGT |
|
|
宇樹科技IPO點燃具身智能行情 首程控股（0697.HK）迎來「投資兌現+平台重估」雙重催化
09:12 HKT/SGT |
|
|
宇树科技IPO点燃具身智能行情 首程控股（0697.HK）迎来"投资兑现+平台重估"双重催化
08:47 HKT/SGT |
|
|
Unitree Robotics IPO Ignites Embodied-Intelligence Rally, Shoucheng Holdings (0697.HK) Faces a Dual Catalyst of 'Investment Realisation+Platform Re-Rating'
08:22 HKT/SGT |
|
|
AEM and ASE Enter Strategic Partnership to Accelerate AI and HPC Test Innovation
08:00 HKT/SGT |
|
|
